Studies In Long Range Target Identification

This book provides unique perspectives on the state of the art in multispectral/hyperspectral techniques for early-warning monitoring against chemical, biological and radiological (CB&R) contamination of both surface (e.g. land) and air (e.g. atmospheric) environments through the presentation of a comprehensive survey of the novel spectroscopic methodologies and technologies that are emerging to address the CB&R defense and security challenges of the future. The technical content in this book lends itself to the non-traditional requirements for point and stand-off detection that have evolved out of the US joint services programs over many years. In particular, the scientific and technological work presented seeks to enable hyperspectral-based sensing and monitoring that is in real time and in-line; low in cost and labor requirements; and easy to support, maintain and use in military and security-relevant scenarios.

Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline. There are several challenges to the current drug development pipeline for nervous system disorders. The fundamental etiology and pathophysiology of many nervous system disorders are unknown and the brain is inaccessible to study, making it difficult to develop accurate models. Patient heterogeneity is high, disease pathology can occur years to decades before becoming clinically apparent, and diagnostic and treatment biomarkers are lacking. In addition, the lack of validated targets, limitations related to the predictive validity of animal models - the extent to which the model predicts clinical efficacy - and regulatory barriers can also impede translation and drug development for nervous system disorders. Improving and Accelerating Therapeutic Development for Nervous System Disorders identifies avenues for moving directly from cellular models to human trials, minimizing the need for animal models to test efficacy, and discusses the potential benefits and risks of such an approach. This report is a timely discussion of opportunities to improve early drug development with a focus toward preclinical trials.